Showing results (51-60 of 101) with videos related to
Sort By:
Pageof 11
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 8, 2025
Gender parity in radiation oncology in Germany: a 2024 analysis of professional roles and academic trainingAngela Besserer, Tina Jost, Andrea Wittig, et al.The Laryngoscope|May 29, 2021
Long-Term Facial Nerve Outcome in Primary Parotid Cancer Surgery: A Population-Based AnalysisJovanna Thielker, Ali Wahdan, Jens Buentzel, et al.Plos One|March 19, 2016
Safety and Efficacy of Botulinum Toxin to Preserve Gland Function after Radiotherapy in Patients with Head and Neck Cancer: A Prospective, Randomized, Placebo-Controlled, Double-Blinded Phase I Clinical TrialAfshin Teymoortash, Andreas Pfestroff, Andrea Wittig, et al.Diagnostics (Basel, Switzerland)|March 13, 2025
Patient Shielding in Ultra-High-Resolution Cone-Beam CT of the Upper Extremity with a Twin Robotic X-Ray SystemAndreas Steven Kunz, Stefan Weick, Jan-Peter Grunz, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 3, 2023
Assessment of dual-energy computed tomography derived virtual monoenergetic imaging for target volume delineation of brain metastasesJohannes Kraft, Paul Lutyj, Felix Grabenbauer, et al.Cancers|June 24, 2022
Role of Intraparotid and Neck Lymph Node Metastasis in Primary Parotid Cancer Surgery: A Population-Based AnalysisMussab Kouka, Benjamin Koehler, Jens Buentzel, et al.Cancers|November 21, 2020
Gender Disparities in Epidemiology, Treatment, and Outcome for Head and Neck Cancer in Germany: A Population-Based Long-Term Analysis from 1996 to 2016 of the Thuringian Cancer RegistryAndreas Dittberner, Benedikt Friedl, Andrea Wittig, et al.Journal of Cellular and Molecular Medicine|July 16, 2009
EORTC trial 11001: distribution of two 10B-compounds in patients with squamous cell carcinoma of head and neck, a translational research/phase 1 trialAndrea Wittig, Laurence Collette, Klaas Appelman, et al.Cancers|May 11, 2024
The Safety and Efficacy of the Combination of Sacituzumab Govitecan and Palliative Radiotherapy-A Retrospective Multi-Center Cohort StudyDavid Krug, Joke Tio, Ali Abaci, et al.Cancers|February 23, 2020
Dual PI3K/mTOR Inhibitor NVP-BEZ235 Enhances Radiosensitivity of Head and Neck Squamous Cell Carcinoma (HNSCC) Cell Lines Due to Suppressed Double-Strand Break (DSB) Repair by Non-Homologous End JoiningUlrike Schötz, Viola Balzer, Friedrich-Wilhelm Brandt, et al.Pageof 11